Dividend Kings Expand to 56 Members, Healthcare Sector Contributes Four Resilient Players Nov 18, 2025 Life Science
With Capital and Policy Working in Tandem, Biotechnology ETFs Present a Strategic Investment Opportunity Nov 17, 2025 Life Science
AbbVie Stock Dips Post-Earnings, But Strong Immunology Pipeline and Dividend Offer Solid Foundation Nov 17, 2025 Life Science
Trump Strikes Deal with Lilly and Novo Nordisk, Slashing Prices of Weight-Loss Drugs Nov 16, 2025 Life Science
Amgen’s Strong Q3 Performance and Multi-Faceted Strategy Drive Long-Term Value Nov 11, 2025 Life Science
GLP-1 Price Cut Storm: Lilly and Novo Nordisk Engage in Strategic “Volume-for-Value” Game Nov 10, 2025 Life Science
AstraZeneca Soars on Positive Trial Results for Hypertension Drug and Strong Earnings Nov 10, 2025 Life Science
Metsera’s Impressive Clinical Data for Weight-Loss Drug Sparks Bidding War Among Pharma Giants Nov 6, 2025 Life Science
U.S. Government Facilitates Historic Price Cut for Weight-Loss Drugs, with an Agreed Price of $245 Nov 6, 2025 Life Science
Beyond the Tech Titans: An AI Stock With a Different Kind of Disruption Nov 4, 2025 Life Science, Technology
Experiments, Mergers, and Interest Rate Cuts: The Biotechnology Sector Ushers in a New Cycle Nov 4, 2025 Life Science
Metsera’s Weight-Loss Drug Technology Sparks Bidding War Among Giants as Stock Price Quadruples in a Month Nov 4, 2025 Life Science
